Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Chronic kidney disease
•
Nephrology
•
Primary Care
What is your approach to managing constipation in patients with chronic kidney disease?
Related Questions
What are your criteria for starting tolvaptan in adult patients diagnosed with autosomal dominant polycystic kidney disease?
Would you avoid SGLT2 inhibitors in patients with urinary incontinence requiring incontinence briefs due to concern with genitourinary hygiene and risk for infections?
What is your approach to managing hyperkalemia in pregnant patients with chronic kidney disease?
Do you recommend patients with chronic kidney disease avoid supplements containing creatine?
Is your decision to prescribe empagliflozin for CKD patients without albuminuria influenced by a recent cost-utility analysis showing that empagliflozin was not cost-effective for this group?
How long do you monitor proteinuria after starting an SGLT-2 inhibitor before considering adding another medication if proteinuria is not at goal?
Do you offer home administration of ESAs for your patients with anemia of chronic kidney disease?
What is your approach to patients with advanced chronic kidney disease who are taking aluminum containing medications?
What is your approach to genetic counseling prior to obtaining genetic testing in young asymptomatic patients suspected of having autosomal dominant polycystic kidney disease?
Would you avoid SGLT2 inhibitors in patients with nephrostomy tubes?
